These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3550692)

  • 1. [Expansion of erythropoiesis and granulopoiesis after bone marrow grafts].
    Rio B; Cadiou M; Andreu G; Ifrah N; Teyssandier I; Coly E; Soria J; Zittoun R
    Nouv Rev Fr Hematol (1978); 1986; 28(6):349-54. PubMed ID: 3550692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia.
    Marmont AM
    Nouv Rev Fr Hematol (1978); 1979; 21(2):133-48. PubMed ID: 390494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone marrow transplantation in cancer patients].
    Morishima Y
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2922-9. PubMed ID: 3532958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
    Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How extensive are the present indications for bone marrow transplantation?].
    Gmür J
    Schweiz Med Wochenschr; 1985 May; 115(21):738-43. PubMed ID: 3892662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation: current status.
    Dinsmore R; O'Reilly RJ
    Pathobiol Annu; 1982; 12():213-31. PubMed ID: 6761631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A; Barak V; Novick D; Nagler A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications and results in bone marrow transplantation].
    Jeannet M; Chapuis B
    Ther Umsch; 1986 Feb; 43(2):138-43. PubMed ID: 3515608
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis.
    Elfenbein GJ; Anderson PN; Humphrey RL; Mullins GM; Sensenbrenner LL; Wands JR; Santos GW
    Transplant Proc; 1976 Dec; 8(4):641-6. PubMed ID: 136774
    [No Abstract]   [Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
    Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
    Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation: experience with 92 patients.
    Selby GB; Saez RA; Epstein RB; Slease RB; Confer DL
    J Okla State Med Assoc; 1993 Dec; 86(12):599-603. PubMed ID: 8126587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
    Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
    Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allogenic bone marrow transplantation in the treatment of malignant hematologic disease].
    Barriga F; Bertín P; Baeza R; Pereira J; Schwartzmann L; Oliva J; Ocqueteau M; Sapunar F; Duhalde M; Lira P
    Rev Med Chil; 1995 May; 123(5):605-11. PubMed ID: 8525207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.